Industry News
Barrett's Patients Who Smoke Are Twice As Likely To Develop Esophageal Cancer
Feb 01, 2012
Barrett's esophagus (BE) patients who smoke tobacco are at a two-fold increased risk of developing esophageal cancer, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association. BE patients who smoke also double their risk for developing advanced precancerous cells... Read More
Defects In The Packaging Of DNA In Malignant Brain Tumors
Feb 01, 2012
Glioblastomas grow extremely aggressively into healthy brain tissue and, moreover, are highly resistant to radiation therapy and chemotherapy. Therefore, they are regarded as the most malignant type of brain tumor. Currently available treatment methods are frequently not very effective against this type of cancer... Read More
FDA Approves Drug For Common Skin Cancer
Feb 01, 2012
On Monday, the US Food and Drug Administration approved a new type of drug to treat adult patients with advanced basal-cell carcinoma, the most common type of skin cancer. The drug's generic name is vismodegib and was developed by the US part of Roche Holding AG. It will be sold in the US by Roche's South San Francisco-based Genentech under the brand name Erivedge... Read More
Alcohol Consumption And Risk Of Colon Cancer In People With A Family History Of Such Cancer
Feb 01, 2012
A study based on more than 87,000 women and 47,000 men in the Nurses' Health Study and the Health Professionals Follow-up Study, looks at whether there is a link between colon cancer and alcohol, and if so at what level of consumption, and the importance of a family history of the disease. A total of 1,801 cases of colon cancer were diagnosed during follow-up from 1980 onwards... Read More
Childhood Brain Tumors Linked To Newly Discovered Mutations
Jan 31, 2012
A recent study published in the online edition of the scientific journal Nature Genetics of rare, lethal childhood tumors of the brainstem has revealed that almost 80% of tumors contain gene mutations that have previously not been associated with cancer. According to early evidence, gene alterations also implicate other aggressive pediatric brain tumors... Read More
FDA Approves Drug For Common Skin Cancer
Jan 31, 2012
On Monday, the US Food and Drug Administration approved a new type of drug to treat adult patients with advanced basal-cell carcinoma, the most common type of skin cancer. The drug's generic name is vismodegib and was developed by the US part of Roche Holding AG. It will be sold in the US by Roche's South San Francisco-based Genentech under the brand name Erivedge... Read More
Inherited Risk Factors For Childhood Leukemia Are More Common In Hispanic Patients
Jan 31, 2012
Hispanic children are more likely than those from other racial and ethnic backgrounds to be diagnosed with acute lymphoblastic leukemia (ALL) and are more likely to die of their disease. Work led by St. Jude Children's Research Hospital scientists has pinpointed genetic factors behind the grim statistics... Read More
Inherited Risk Factors For Childhood Leukemia Are More Common In Hispanic Patients
Jan 31, 2012
Hispanic children are more likely than those from other racial and ethnic backgrounds to be diagnosed with acute lymphoblastic leukemia (ALL) and are more likely to die of their disease. Work led by St. Jude Children's Research Hospital scientists has pinpointed genetic factors behind the grim statistics... Read More
New Drug Release Mechanism Developed That Utilizes 3D Superhydrophobic Materials
Jan 31, 2012
According to a recent study, there is a new mechanism of drug release using 3D superhydrophobic materials that utilizes air as a removable barrier to control the rate at which drug is released. The study was electronically published in the Journal of the American Chemical Society... Read More
Major Challenge Of Drug Delivery Addressed By Researchers' Innovation
Jan 31, 2012
A new physical form of proteins developed by researchers at The University of Texas at Austin could drastically improve treatments for cancer and other diseases, as well as overcome some of the largest challenges in therapeutics: delivering drugs to patients safely, easily and more effectively... Read More
Previous Page Next Page